Skip to Content
Merck
  • Improved sensitivity to fluorescence for cancer detection in wide-field image-guided neurosurgery.

Improved sensitivity to fluorescence for cancer detection in wide-field image-guided neurosurgery.

Biomedical optics express (2015-12-30)
Michael Jermyn, Yoann Gosselin, Pablo A Valdes, Mira Sibai, Kolbein Kolste, Jeanne Mercier, Leticia Angulo, David W Roberts, Keith D Paulsen, Kevin Petrecca, Olivier Daigle, Brian C Wilson, Frederic Leblond
ABSTRACT

In glioma surgery, Protoporphyrin IX (PpIX) fluorescence may identify residual tumor that could be resected while minimizing damage to normal brain. We demonstrate that improved sensitivity for wide-field spectroscopic fluorescence imaging is achieved with minimal disruption to the neurosurgical workflow using an electron-multiplying charge-coupled device (EMCCD) relative to a state-of-the-art CMOS system. In phantom experiments the EMCCD system can detect at least two orders-of-magnitude lower PpIX. Ex vivo tissue imaging on a rat glioma model demonstrates improved fluorescence contrast compared with neurosurgical fluorescence microscope technology, and the fluorescence detection is confirmed with measurements from a clinically-validated spectroscopic probe. Greater PpIX sensitivity in wide-field fluorescence imaging may improve the residual tumor detection during surgery with consequent impact on survival.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
5-Aminolevulinic acid hydrochloride, BioReagent, suitable for cell culture, powder, ≥98%
Sigma-Aldrich
5-Aminolevulinic acid hydrochloride, ≥98%